We are bringing a biology-first approach and integrating a deep expertise in cell models, machine learning and high throughput technologies to develop new and more effective therapies.
With our focus on harnessing the power of AI and machine learning, we are crafting an innovative atlas of antibody targets on the surface of cancer cells.
This sets the stage for groundbreaking discoveries of new cancer targets and the development of improved therapeutics.
This sets the stage for groundbreaking discoveries of new cancer targets and the development of improved therapeutics.
At TenSixty, we're not just chasing after new targets; we're on a mission to create transformative drugs that will save lives and redefine oncology.
We are an interdisciplinary team with expertise spanning biology, ML, and technology development.
We not only see a tremendous opportunity but also responsibility in pursuing the translation of our research from bench to bedside. The TenSixty team embraces data and well-crafted experiments to develop novel treatments that have not been imagined before.
We treat everyone with dignity and professionalism.
We work as a team and look out for each other.
We drive towards our ambitious goals with grit and determination.
